Novo Integrated Sciences, Inc. (NVOS)
| Market Cap | 39.24M |
| Revenue (ttm) | 10.31M |
| Net Income (ttm) | -5.50M |
| Shares Out | 28.65M |
| EPS (ttm) | -0.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,442 |
| Open | 1.30 |
| Previous Close | 1.32 |
| Day's Range | 1.28 - 1.37 |
| 52-Week Range | 1.20 - 14.98 |
| Beta | -0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About NVOS
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and base...
Financial Performance
Financial StatementsNews
Novo Integrated Sciences Reports First Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Reports First Quarter Financial Results
Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Announces Signing of a Master Facility License Agreement with LA Fitness in Canada
Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results
Novo Integrated Sciences Acquires Majority Stake in Terragenx
Novo Integrated Sciences Inc (NASDAQ: NVOS) has acquired 91% of Terragenx through an all-share transaction at $3.35 per share. The human immune system uses iodine to deactivate viruses in the bloodstre...
Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada App...
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences Acquires 91% Stake in Terragenx and IP for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient
Novo Integrated Sciences' subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanc...
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #Benzinga--Novo Integrated Sciences' subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform
Novo Integrated Sciences Signs LOIs to Acquire 7 Pharmacies in the US
Image provided by Tbel Abuseridze on Unsplash Novo Integrated Sciences, Inc. (NASDAQ: NVOS), a pioneer in holistic, patient-first health and wellness services and products, has signed letters of intent ...
Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #NovoConnect--Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States
Novo Integrated Sciences' Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutritio...
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #biotech--Co-Founded by Mark Wahlberg and industry executive, Tom Dowd, PI Nutrition completes a licensing agreement with Aceniza, Inc. (an NVOS subsidiary).
Novo Integrated Sciences Launches New Patient Portal App Giving Patients More Control Over Their Healthcare
The ‘new' reality of the COVID-19 pandemic, ongoing advancements in medical technology, inter-connectivity, and blockchain technology, are all key drivers in the global healthcare system making critical...
Novo Integrated Sciences Announces Third Quarter 2021 Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Third Quarter 2021 Financial Results
Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer
Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia
Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.
Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC
Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC
Novo Integrated Sciences Announces Formation of Medical Advisory Board
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Formation of Medical Advisory Board
Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering
Novo Integrated Sciences Announces Second Quarter 2021 Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Second Quarter 2021 Financial Results
Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering
Novo Integrated Sciences Announces Preliminary Revenue and Financial Results of Second Quarter Fiscal Year ‘21
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Preliminary Revenue and Financial Results of Second Quarter Fiscal Year ‘21
Novo Integrated Sciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conferenc...
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, March 17-19, 2021
Novo Integrated Sciences Announces New Executive Hires for Novo Healthnet Limited
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences (NASDAQ:NVOS) Announces New Executive Hires for Novo Healthnet Limited
NVOS Stock Alert: 5 Things to Know About Novo Integrated Sciences as It Blasts Higher
Novo Integrated Sciences (NVOS) stock is taking off on Wednesday following an uplist to the Nasdaq Exchange and heavy trading of its shares. The post NVOS Stock Alert: 5 Things to Know About Novo Integr...